Posts by Magali Bischof
UNIGE – Medicines made of solid gold
Medicines made of solid gold to help the immune system By studying the effects of gold nanoparticles on the immune cells related to antibody production, researchers at UNIGE, Swansea University and the NCCR “Bio-inspired Materials” are paving the way for more effective vaccines and therapies. Over the past twenty years, the use of nanoparticles…
Read MoreUNIGE – Detecting problems of the anti-bleeding system in 60 minutes
UNIGE and Franche-Comté University researchers have co-developped an innovative device enabling platelet capacity detection This tool investigates a patient’s platelet capacity in near real-life conditions so that bleeding can be stopped (haemostasis). “Various diseases can cause haemorrhages or thromboses, sometimes fatal, resulting in particular from complications during surgery. This may take the form of…
Read MoreUNIGE : Yves Flückiger appointed as Rector for a second term
The appointment of the new rectorate of UNIGE by the Council of State was revealed on Thursday 20 June 2019. Prof. Dr. Yves Flückiger was appointed at the head of the rectorate for a second 4 year term. The rectorate’s new structure underlines the academic institution’s strategic goal to focus on innovation, digital transformation and sustainability.…
Read MoreThe Wyss Center has a new Director
Dr Mary Tolikas has been appointed as the new Director of the Wyss Center “The Executive Board of the Wyss Center for Bio and Neuroengineering has announced that Dr Mary Tolikas will assume responsibility as Executive Director on 1st June 2019, taking over from Professor John Donoghue. Dr Tolikas has more than twenty years’ experience…
Read MoreUNIGE and UNIL : “A model to decipher the complexity of gene regulation”
Scientist at the Universities of Geneva and Lausanne, Switzerland, designed a framework to analyse gene regulation, and offer a model to better understand the role of the non-coding portion of the genome in disease risk. More than genes themselves, how, where and when they are expressed determine our biological traits – our phenotypes. If gene…
Read MoreAsceneuron : New member appointed to the Board of Directors
Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today announces the appointment of Dr Eric Yuen to its Board of Directors.
Read MoreThe 2019 Global Startup Ecosystem Report is now available!
The Bern-Lausanne-Geneva region has been ranked #22 worldwide in this year’s edition of the Global Startup Ecosystem Report Not only are key Health Valley players contributing to the rise of Switzerland’s excellence when it comes to startup growth support, but western Switzerland region’s achievements in the life sciences sector has also been highly ranked. Indeed, the…
Read MoreThe Swiss Integrative Center for Human Health (SICHH) and the Human Brain Project (HBP) unite
The SICHH and the HBP unite to further research on Alzheimer’s disease and dementia. The SICHH welcomes the HBP team in Fribourg to support them in the search for treatment against Alzheimer’s disease and dementia. The integration of competencies within a small structure fosters crucial discoveries at the highest research level. Read the…
Read MoreDeep Cube – A Success Story
Watch Deep Cube‘s video and learn more about one the canton of Vaud’s striving startups!
Read MoreBack to the sources of neural diversity
By deciphering the genetic programmes of neurons of the cerebral cortex, Swiss and Belgian researchers unravel the mechanisms controlling the genesis of cells in one of the most essential parts of our brain. The cortex is a complex brain region that allows us to perceive the world and interact with objects and beings around us.…
Read More